By RONI CARYN RABIN
A government task force suggested that providers pay more for lifesaving generics and that drug makers receive quality ratings.
Published: October 28, 2019 at 08:00PM
from NYT Health https://ift.tt/31VKZn0
via IFTTT
from WordPress https://ift.tt/2q56HYc
via IFTTT
No comments:
Post a Comment